SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs&Pharma - Quaterly Results

14 Aug 2024 Evaluate
The revenue slipped marginally during the June 2024 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2024 is Rs. -3.45 millions as compared to Net Loss of Rs. -0.30 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 further decreased to -3.43% as compared to -0.30% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.94 2.37 -60.34
PBIDT -3.43 -0.30 1043.33 -3.43 -0.30 1043.33 -1.39 1.05 -232.38
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -3.43 -0.30 1043.33 -3.43 -0.30 1043.33 -1.39 1.05 -232.38
Depreciation 0.02 0.00 0.00 0.02 0.00 0.00 0.36 0.03 1100.00
PBT -3.45 -0.30 1050.00 -3.45 -0.30 1050.00 -1.75 1.02 -271.57
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.45 -0.30 1050.00 -3.45 -0.30 1050.00 -1.75 1.02 -271.57
Equity 134.39 134.39 0.00 134.39 134.39 0.00 134.39 134.39 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Welcure Drugs&Pharma Share Price

0.32 -0.01 (-3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×